Question to the Department of Health and Social Care:

To ask His Majesty's Government how they are monitoring the impact of the maternal respiratory syncytial virus vaccination programme on paediatric hospitalisations; and what steps they are taking to assess and improve the programme.

Through the Severe Acute Respiratory Infection Watch programme, the UK Health Security Agency (UKHSA) undertakes surveillance of hospitalisations due to confirmed respiratory syncytial virus (RSV).

The UKHSA also undertakes monitoring and evaluation of immunisation programmes, including the effectiveness of vaccines in preventing hospital admissions. Such an analysis is being developed for the maternal vaccination programme for infant RSV prevention.

The UKHSA also provided analysis on RSV prevention considerations for very and extremely premature babies as part of the October 2024 meeting of the Joint Committee on Vaccination and Immunisation.